Capital deployed into sectors that will shape the future of human living — real assets, preventive healthcare, wellness infrastructure, and knowledge systems.
Our investment philosophy is grounded in long-term structural transformation. We deploy capital into sectors that we believe will shape the future of human living — including real assets, preventive healthcare, wellness infrastructure, and knowledge systems.
We focus on opportunities where demographic change, rising health awareness, urban evolution, and institutional demand create enduring relevance across economic cycles.
Through disciplined capital allocation, operational stewardship, and ecosystem thinking, we build scalable platforms designed to generate sustainable returns, resilient asset value, and long-term societal impact.

Investing in and operating institutional-grade real assets designed to deliver enduring utility, resilient value, and long-term relevance.
Developing next-generation healthspan platforms that integrate clinical science, wellness infrastructure, artificial intelligence, and preventive healthcare.
Developing institutional knowledge and applied research to strengthen long-term innovation and organizational resilience.
Capital is structured through multiple investment models, each aligned to the maturity, governance requirements, and strategic objectives of the underlying platform.
Full control for foundational assets. Establishing standards, governance, and brand.
Strengthen capital structure, accelerate scaling while maintaining control. Partners selected for long-term alignment.
Diversify funding, improve capital efficiency. Co-investors join with defined governance roles.
Geographic expansion and platform replication. Local expertise for new market entry.
Long-term ownership in residential, office, and industrial assets, supported by leasing and management capability.
Collaborations with investors and strategic partners to access a broader opportunity set and deliver capital solutions aligned with long-term stewardship.
Integrated platforms that advance human health, longevity, and well-being.
Our platforms are the institutional operating structures through which we deploy capital, steward strategic assets, and scale long-term value creation across real estate, healthcare, and wellness ecosystems.

Property Development & Infrastructure
Hanco 9 is the Group's real estate development and infrastructure platform, focused on residential, industrial, and mixed-use assets across Northern Vietnam.
View Platform
Office Leasing & Operations
Property One is the Group's commercial asset management platform, overseeing office leasing, tenant engagement, operational performance, and long-term capital planning across the Group's office portfolio in Hanoi.
View Platform
Wellness Estate Development & Operations
Unik Green is the Group's wellness real estate and destination development platform, focused on building institutional-grade wellness environments that integrate hospitality, nature, and long-term community living.
View Platform
Integrated Healthcare System & Human Capital Platform
Chitta Group is the Group's integrated healthcare, healthspan, and human capital platform, responsible for clinical operations, preventive healthcare systems, education, and intellectual property development.
View Platform
Phú Thọ Province, Vietnam

No 4 Lieu Giai, Ba Dinh, Hanoi

390 Nguyễn Văn Cừ, Long Biên, Hanoi

98a P. Nguỵ Như Kon Tum, Thanh Xuân, Hanoi
Thu Lam Commune, Dong Anh, Hanoi
Unik's investment evolution reflects a structured progression from foundational asset development to platform scaling and ecosystem monetization.
Core asset base established and operational. Healthspan platform concept developed and validated. Governance framework defined.
Real Assets ~70% · R&D ~15% · Technology ~10% · Operations ~5%
Institutional governance fully operational. Strategic partnerships secured. Capital integrated for platform scaling. CHI research capability established.
Real Assets ~75% · R&D ~12% · Technology ~10% · Ops ~3% · Target: ~USD 100M deployed
Chitta Retreat Phase 1 operational. Revenue generation and occupancy stabilisation achieved. Clinical model validated at scale. Technology integrated across platforms.
Real Assets ~72% · R&D ~13% · Technology ~12% · Ops ~3% · Target EBITDA margins: ~27 – 35%
Full ecosystem integration across assets, platforms, and services. Multiple revenue streams operational. Monetisation pathways established including potential IPO readiness.
Real Assets ~80% · R&D ~8% · Technology ~10% · Ops ~2%
Strategic partnerships and co-investment opportunities for aligned capital partners who share our time horizon and governance standards.
Partnership InquiryDirect investment across our platform portfolio — for institutional investors, family offices, and qualified individuals seeking long-duration, asset-backed exposure.
Investor RelationsSpeak with our capital partners team to learn more about strategy, governance, and partnership opportunities.
Made with Emergent